CEG Research Update — September 22, 2026
Updated Thesis
Constellation Energy is the largest U.S. producer of carbon-free electricity, operating roughly 32,400 megawatts of nuclear, gas, wind, solar, and hydro generation across the Mid-Atlantic, Midwest, New York, ERCOT, and other power markets, with a 94.9% TTM gross margin that reflects the low marginal cost of nuclear fuel and the scarcity value of firm clean power. The business quality is genuinely high, but the stock is not cheap: at $262.11 the shares trade at 26.68 times trailing earnings, 13.88 times EV/EBITDA, and 300.28 times trailing free cash flow, with a $0.87 FCF per share against $87.08 of revenue per share, and the quantitative model puts fair value at $250.98, implying 4.2% downside to fair value, or a 4.4% premium to that estimate.
The investment grade as of this refresh is C — average business quality. A-tier business, C-tier valuation: 4.2% downside to $250.98 fair value despite a Strong Buy consensus and 40.8% upside to the $369 target.
Key Metrics at a Glance
- Revenue growth: +23.0% year over year
- Net margin: 11.1%
- Fair value upside: -4.2% to our estimate of $251
Current price: $262.11
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Constellation Energy Corporation remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full CEG research →](/stocks/CEG)